tukysa
seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - agentes antineoplásicos - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.
ceumid 100 mg/ml solución oral
megapharma labs de ceam, sociedad anónima - solución oral - 500 mg
genotropin liofilizado para solución inyectable 16 u.i./ml con solvente (somatropina)
pfizer chile s.a. - somatropina - sin formulas
genotropin liofilizado para solución inyectable 36 u.i./ml con solvente (somatropina)
pfizer chile s.a. - somatropina - sin formulas
sildenafil 100 mg
medior hearthcare pvt. ltd. india - sildenafil 100 mg - tabletas masticables - cada tableta masticable contiene sildenafil citrato 141 mg equivalente a: sildenafil 100 mg
echinacin madaus 800mg/ml solució oral 50 ml
lioresal 10 mg 30 comprimits
lioresal 25 mg 30 comprimits
lisinopril grindeks 5 mg comprimidos efg, 60 comprimidos
lisinopril grindeks 10 mg comprimidos efg, 28 comprimidos